Eli Lilly also presented new data on its second-generation drug retatrutide, which combines GLP-1, GIP, and glucagon, finding it improved insulins ability to control blood sugar in people with type 2 diabetes
However, some patients anecdotally report mood changes, which may be related to hypoglycaemia, gastrointestinal discomfort, or diabetes-related stress rather than a direct effect of the medication
On average, people taking semaglutide (Wegovy) for weight management lose 10-15% of their body weight from baseline after 6 months
CJC-1295 is engineered to mimic and extend the action of endogenous GHRH, with a significantly longer half-life due to modifications that allow it to bind to albumin in the bloodstream
This increases side effects and reduces efficacy
04Direct message access Reach your provider directly between check-ins in English or Spanish via your secure portal